Argus raised the firm’s price target on Elevance Health (ELV) to $465 from $450 and keeps a Buy rating on the shares. The company’s results ...

Shares of Elevance Health Inc. ELV slid 1.66% to $421.68 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.74% to 5,525.21 ...

Pharmacists play an indispensable role in the healthcare system across a variety of settings – community pharmacies, primary care facilities, hospitals, health plans, and pharmacy benefit managers ...